Revive Therapeutics To Raise Up To $5M Via Private Placement
Revive Therapeutics To Raise Up To $5M Via Private Placement
REVIVE THERAPEUTICS LTD. (OTCQB:RVVTF) (CSE:RVV) announced that it is arranging a private placement of a minimum of $3 million and up to $5 million of units, at a price of $0.15 per unit;. The offering is being led by EMD Financial Inc.
复兴治疗有限公司。(OTCQB：RVVTF)(CSE：RVV)宣布安排私募最低300万美元和最高可达500万美元的单位, 售价0.15美元每单位；此次发行由以下公司牵头EMD金融公司.
Each unit shall be comprised of one common share in the capital of the company and one common share purchase warrant of the company. Each warrant shall entitle the holder thereof to acquire one additional common share at a price of $0.20 for a period of thirty-six months from the closing date of the offering.
每单位由一股公司股本普通股和一份公司普通股认购权证组成。每份认股权证持有人有权以0.20美元的价格额外购买一股普通股，期限为自发售结束之日起36个月。
The company intends to use the net proceeds for general working capital purposes and clinical development.
该公司打算将净收益用于一般营运资金用途和临床开发。
In connection with the offering, the company will pay finder's fees and issue finder warrants to EMD Financial Inc. as well as any other registrants participating in the offering consisting of: cash finder's fees of up to 8% of the gross proceeds of the offering and finder warrants in an amount equal to up to 8% of the number of units issued pursuant to the offering, exercisable at a price of $0.15 per common share for a period of thirty-six months following the closing date.
与此次发售相关的是，该公司将向EMD金融公司以及参与此次发售的任何其他注册人支付寻金手续费，并向参与发售的任何其他注册人发行寻得股权证，包括：最高为发售总收益的8%的现金寻回手续费和金额不超过根据发售发行的单位数量的8%的寻回股权证，可在交易截止日期后的36个月内以每股普通股0.15美元的价格行使。
The units offered as a part of the offering shall be offered to purchasers resident in all provinces of Canada, except Québec, pursuant to the listed issuer financing exemption under Part 5A of NI 45-106. The company may issue up to an aggregate of 33.33 million units for maximum aggregate gross proceeds of $5 million under the listed issuer financing exemption. Units offered under the listed issuer financing exemption will not be subject to resale restrictions pursuant to applicable Canadian securities laws.
根据NI 45-1065A部分下的上市发行人融资豁免，作为发售一部分的发售单位应向居住在加拿大所有省份(QuéBEC除外)的买家发售。该公司可以发行最多一份总计3333万套上市发行人融资豁免项下的最高总收益总额为500万美元。根据适用的加拿大证券法，根据上市发行人融资豁免提供的单位将不受转售限制。
The offering is anticipated to close on or about December 14, 2022, or such later date as the company may determine. The closing is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and other approvals, including the approval of the Canadians Securities Exchange.
这份礼物是预计于2022年12月14日左右关闭，或公司决定的较后日期。成交取决于某些条件，包括但不限于获得所有必要的监管和其他批准，包括加拿大证券交易所的批准。
Get your daily dose of cannabis news on Benzinga Cannabis. Don't miss out on any important developments in the industry.
获取您的每日大麻用量新闻 在本辛加大麻上。不要错过对该行业任何重要发展的期望。
Photo by Mackenzie Marco on Unsplash
Mackenzie Marco在Unspash上的照片
Related News
相关新闻
Major Psychedelics Firm Is Studying Magic Mushrooms To Treat Meth Addiction
大型迷幻药公司正在研究魔力蘑菇治疗冰毒成瘾